http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110872267-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2018-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110872267-B |
| titleOfInvention | Compound extracted from paper mulberry and application of compound in preparation of protein tyrosine phosphatase 1B inhibitor |
| abstract | The present invention belongs to the field of medicine technologyThe technical field relates to an isopentenyl flavonol compound with a structure shown in a formula (I) and application thereof. In particular to a compound 2- [3, 4-dihydroxy-5- (3-methyl-2-butenyl) benzene]-8- [ (2E) -3, 7-dimethyl-2, 6-octadienyl]-3, 5, 7-trihydroxy-4H-benzopyran-4-ketone and application thereof as a protein tyrosine phosphatase 1B inhibitor in preparing medicines for preventing or treating type 2 diabetes. Experiments prove that the compound has strong inhibitory activity on protein tyrosine phosphatase 1B, can be used for developing a novel lead compound for preventing or treating type 2 diabetes, or can be used for preparing a medicament for preventing or treating clinically common and frequent type 2 diabetes. |
| priorityDate | 2018-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 163.